Cell Lysis Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

Cell Lysis Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022 - 2028

Report Description
Cells contain biomolecules such as proteins or nucleic acids present in the cytoplasm and enclosed within a membrane. Cell lysis is a process in which a cell membrane is ruptured due to some external forces or conditions such as viral infection or osmosis, resulting in the release of cell contents, thus in subsequent death of the cell. In industries and research laboratories, cell lysis is often used to break open the cell to study its internal components. The two methods through which cell lysis can be achieved include mechanical and chemical methods. Mechanical cell lysis method includes high shear mixing, sonication, freeze or thaw cycles, traditional homogenization, grinding, and high pressure homogenization whereas, chemical lysis method comprises osmotic lysis, and the use of detergents, chelating agents.
Market Dynamics
The global cell lysis market is projected to witness significant growth over the forecast period, owing to increasing prevalence of chronic diseases and increasing development in cell lysis by key market players. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015 data findings, 5,251 deaths were reported due to influenza infection in 2015, in the U.S. Furthermore, according to a National Cancer Institute, 2021, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2028. Such increasing prevalence of cancer and infectious disease are expected to drive growth of the cell lysis market. Moreover, increasing research and development expenditure by biopharmaceutical industries and biotechnology industries fosters growth of the cell lysis market. According to 2012 EU Industrial R&D Investment Scoreboard, the pharmaceutical and biotechnology sector represented 17.7% of business R&D expenditure globally. However, high cost of cell based research, owing to high expenditure in research and development for CAR-T cell therapy hampers growth of the cell lysis market.
Key features of the study:
This report provides in-depth analysis of the cell lysis market, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global cell lysis market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
Key companies covered as a part of this study include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Thermo Fisher Scientific, Qiagen N.V., Qsonica, Merck KGaA, and F. Hoffman-La Roche Ltd..
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
The global cell lysis market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for cell lysis products, research and consulting firms, new entrants and financial analysts.

Detailed Segmentation:
Global Cell Lysis Market, By Product Type:
Instruments
Consumables
Global Cell Lysis Market, By Cell Type:
Mammalian Cells
Microbial Cells
Other Cells
Global Cell Lysis Market, By End User:
Academic and Research Labs
Pharmaceutical and Biotechnology Companies
Global Cell Lysis Market, By Region:
North America
By Country:
U.S.
Canada
By Product Type:
Instruments
Consumables
By Cell Type:
Mammalian Cells
Microbial Cells
Other Cells
By End User:
Academic and Research Labs
Pharmaceutical and Biotechnology Companies
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Instruments
Consumables
By Cell Type:
Mammalian Cells
Microbial Cells
Other Cells
By End User:
Academic and Research Labs
Pharmaceutical and Biotechnology Companies
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Instruments
Consumables
By Cell Type:
Mammalian Cells
Microbial Cells
Other Cells
By End User:
Academic and Research Labs
Pharmaceutical and Biotechnology Companies
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Instruments
Consumables
By Cell Type:
Mammalian Cells
Microbial Cells
Other Cells
By End User:
Academic and Research Labs
Pharmaceutical and Biotechnology Companies
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Instruments
Consumables
By Cell Type:
Mammalian Cells
Microbial Cells
Other Cells
By End User:
Academic and Research Labs
Pharmaceutical and Biotechnology Companies
Africa
By Country:
South Africa
North Africa
Central Africa
By Product Type:
Instruments
Consumables
By Cell Type:
Mammalian Cells
Microbial Cells
Other Cells
By End User:
Academic and Research Labs
Pharmaceutical and Biotechnology Companies
Company Profiles
Becton, Dickinson and Company*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Thermo Fisher Scientific Inc.
Merck KGaA
Qiagen N.V.
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc.
Cell Signalling Technology, Inc.
Qsonica
“*” marked represents similar segmentation in other categories in the respective section.